These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12796606)

  • 1. Simple staging criteria for esophageal carcinoma: classification with a strict prognostic stratification.
    Nozoe T; Sugimachi K
    Am J Clin Oncol; 2003 Jun; 26(3):307-11. PubMed ID: 12796606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All pathological T4 esophageal carcinomas should be categorized as stage IV.
    Tabira Y; Yasunaga M; Nakano KY; Sakaguchi T; Nagamoto N; Matsushita H; Fukunaga Y
    Hepatogastroenterology; 2002; 49(45):694-8. PubMed ID: 12063972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An audit of surgical outcomes of esophageal squamous cell carcinoma.
    Goan YG; Chang HC; Hsu HK; Chou YP
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):536-44. PubMed ID: 17222561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing an appropriate staging system for esophageal carcinoma.
    Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
    J Am Coll Surg; 2005 Dec; 201(6):884-90. PubMed ID: 16310691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation.
    Chirieac LR; Swisher SG; Ajani JA; Komaki RR; Correa AM; Morris JS; Roth JA; Rashid A; Hamilton SR; Wu TT
    Cancer; 2005 Apr; 103(7):1347-55. PubMed ID: 15719440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
    Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dukes' classification as a prognostic factor in patients with squamous cell carcinoma of the thoracic esophagus undergoing combined-modality treatment.
    Dabrowski A; Skoczylas T; Ciechański A; Wallner G; Zinkiewicz K; Cwik G; Górczyński R; Borowski A
    Med Sci Monit; 2006 Oct; 12(10):CR409-15. PubMed ID: 17006399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent.
    Mariette C; Piessen G; Briez N; Triboulet JP
    Ann Surg; 2008 Feb; 247(2):365-71. PubMed ID: 18216546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the accuracy of TNM staging in esophageal cancer: a pathological review of resected specimens.
    Thompson SK; Ruszkiewicz AR; Jamieson GG; Esterman A; Watson DI; Wijnhoven BP; Lamb PJ; Devitt PG
    Ann Surg Oncol; 2008 Dec; 15(12):3447-58. PubMed ID: 18830669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphadenectomy extent is closely related to long-term survival in esophageal cancer.
    Kang CH; Kim YT; Jeon SH; Sung SW; Kim JH
    Eur J Cardiothorac Surg; 2007 Feb; 31(2):154-60. PubMed ID: 17145185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.
    Tachibana M; Kinugasa S; Yoshimura H; Shibakita M; Tonomoto Y; Dhar DK; Nagasue N
    Am J Surg; 2005 Jan; 189(1):98-109. PubMed ID: 15701501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
    Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
    Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appraisal of a revised lymph node classification system for esophageal squamous cell cancer.
    Dhar DK; Hattori S; Tonomoto Y; Shimoda T; Kato H; Tachibana M; Matsuura K; Mitsumoto Y; Little AG; Nagasue N
    Ann Thorac Surg; 2007 Apr; 83(4):1265-72. PubMed ID: 17383324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of recurrent esophageal cancer after radical esophagectomy with two- or three-field lymphadenectomy.
    Kato H; Fukuchi M; Miyazaki T; Nakajima M; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Manda R; Ojima H; Tsukada K; Kuwano H
    Anticancer Res; 2005; 25(5):3461-7. PubMed ID: 16101164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma.
    Rizk NP; Venkatraman E; Bains MS; Park B; Flores R; Tang L; Ilson DH; Minsky BD; Rusch VW;
    J Clin Oncol; 2007 Feb; 25(5):507-12. PubMed ID: 17290058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downstaging of T or N predicts long-term survival after preoperative chemotherapy and radical resection for esophageal carcinoma.
    Korst RJ; Kansler AL; Port JL; Lee PC; Kerem Y; Altorki NK
    Ann Thorac Surg; 2006 Aug; 82(2):480-4; discussion 484-5. PubMed ID: 16863749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors?
    Bollschweiler E; Baldus SE; Schröder W; Schneider PM; Hölscher AH
    J Surg Oncol; 2006 Oct; 94(5):355-63. PubMed ID: 16967455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical analysis of 33 cases of primary esophageal small cell carcinoma].
    Duan HB; Wu HY; Su XD; Zeng CG; Dai WQ; Huang L
    Ai Zheng; 2007 Jul; 26(7):771-4. PubMed ID: 17626757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients.
    Tachibana M; Hirahara N; Kinugasa S; Yoshimura H
    Ann Surg Oncol; 2008 Jan; 15(1):104-16. PubMed ID: 17891442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.